D. Ieluzzi

发表

Protease inhibitors‐based therapy induces acquired spherocytic‐like anaemia and ineffective erythropoiesis in chronic hepatitis C virus patients

G. Fattovich, A. Alberti, F. Turrini, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort

M. Massari, F. Morisco, A. Federico, 2020, Hepatology International.

Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort

A. Gasbarrini, M. Massari, G. Foti, 2017, Hepatology.

HCV treatment policy in a real-life cohort

A. Gasbarrini, M. Massari, G. Foti, 2017 .

Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low‐moderate liver fibrosis

M. Montagnana, C. Monaco, D. Roccarina, 2020, Journal of viral hepatitis.

Effects of direct‐acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real‐life Italian experience

A. Mantovani, D. Sacerdoti, A. Dalbeni, 2022, Journal of digestive diseases.

A prospective study of direct‐acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort

M. Massari, A. Benedetti, F. Morisco, 2021, Hepatology.

Progression to cirrhosis, hepatocellular carcinoma and liver-related mortality in chronic hepatitis B patients in Italy.

G. Fattovich, L. Covolo, F. Donato, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C

G. Fattovich, M. Pirisi, C. Fabris, 2012, Hepatology.

Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort.

M. Massari, M. Brunetto, M. Galli, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome.

F. Negro, G. Fattovich, L. Covolo, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Genetic Polymorphisms of Vitamin D Pathway Predict Antiviral Treatment Outcome in Slow Responder Naïve Patients with Chronic Hepatitis C

G. Fattovich, M. Pirisi, C. Fabris, 2013, PloS one.

Complementary role of vitamin D deficiency and the interleukin‐28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C

G. Fattovich, M. Pirisi, C. Fabris, 2011, Hepatology.

Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

Antonio Gasbarrini, Giovanni Raimondo, Marco Massari, 2017, PloS one.

Forecasting Hepatitis C liver disease burden on real‐life data. Does the hidden iceberg matter to reach the elimination goals?

A. Gasbarrini, M. Massari, A. Andriulli, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters

M. Manns, F. Lammert, J. Dufour, 2014, Gut.

Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort.

M. Massari, P. Lampertico, G. Raimondo, 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study

M. Massari, A. Di Leo, G. Raimondo, 2018, PloS one.

Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study

M. Massari, A. Di Leo, G. Raimondo, 2017, PloS one.

Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia

D. Sacerdoti, A. Dalbeni, F. Cattazzo, 2023, Internal and Emergency Medicine.

The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study

E. Tacconelli, E. Carrara, M. Zoncapè, 2023, PloS one.

A. Gasbarrini, M. Massari, M. Colombo, 2016 .

Gender Differences in HCV Chronic Liver Disease: A Real Life Evaluation in Piter (Piattaforma Italiana per Lo Studio Della Terapia Delle Epatiti Virali) Cohort Study

A. Gasbarrini, M. Massari, A. Lazzarin, 2016 .

Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study

M. Massari, A. Di Leo, G. Raimondo, 2017, PloS one.

A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and Delta cohort.

F. Ponziani, F. Foschi, G. Raimondo, 2024, International Journal of Infectious Diseases.